Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Other Operating Expenses (2021 - 2025)

Historic Other Operating Expenses for Macrogenics (MGNX) over the last 5 years, with Q3 2025 value amounting to $11.6 million.

  • Macrogenics' Other Operating Expenses rose 51973.26% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.4 million, marking a year-over-year increase of 35015.78%. This contributed to the annual value of $12.3 million for FY2024, which is 4958.65% up from last year.
  • As of Q3 2025, Macrogenics' Other Operating Expenses stood at $11.6 million, which was up 51973.26% from $8.9 million recorded in Q2 2025.
  • In the past 5 years, Macrogenics' Other Operating Expenses registered a high of $11.6 million during Q3 2025, and its lowest value of $17000.0 during Q1 2021.
  • Over the past 5 years, Macrogenics' median Other Operating Expenses value was $2.1 million (recorded in 2024), while the average stood at $3.0 million.
  • In the last 5 years, Macrogenics' Other Operating Expenses surged by 1081818.18% in 2022 and then tumbled by 9089.89% in 2023.
  • Macrogenics' Other Operating Expenses (Quarter) stood at $947000.0 in 2021, then surged by 89.12% to $1.8 million in 2022, then tumbled by 90.9% to $163000.0 in 2023, then surged by 3268.1% to $5.5 million in 2024, then soared by 111.09% to $11.6 million in 2025.
  • Its Other Operating Expenses was $11.6 million in Q3 2025, compared to $8.9 million in Q2 2025 and $5.4 million in Q1 2025.